Vm. Monnier et al., STRUCTURE OF ADVANCED MAILLARD REACTION-PRODUCTS AND THEIR PATHOLOGICAL ROLE, Nephrology, dialysis, transplantation, 11, 1996, pp. 20-26
In this article we review recent progress and controversies relating t
o three areas of the field of advanced glycosylation end-products (AGE
). A controversy exists as to whether pyrraline, an AGE detectable by
immunohistochemistry in kidneys from patients with renal failure, exis
ts in vivo. Recent data from the authors' laboratory revealed that pyr
raline is present in alkaline or protease digests from human skin and
plasma. However, the amounts are very low and pyrraline was found to u
ndergo further reactions to form an ether with itself (dipyrraline) as
well as a thioether with cysteine. This high reactivity of pyrraline
may explain the difficulty of quantitating it accurately in biological
material. In contrast, the glycoxidation products carboxymethyllysine
(CML) and pentosidine are stable, very resistant to acid hydrolysis a
nd easy to quantitate. They are present in elevated concentrations in
the extracellular matrix in diabetes mellitus and ageing. In the diabe
tic human lens, CML is not elevated, in contrast to pentosidine, sugge
sting a different mechanism of formation. Recent data in diabetic dogs
have shown that pentosidine is elevated only in lenses from poorly co
ntrolled dogs, in contrast to LM-1, a fluorophore thought to arise fro
m ascorbate. Further studies are needed to clarify the intracellular m
echanism of glycoxidation. The greatest concentrations of AGEs and gly
coxidation products are found in patients with end-stage renal disease
, and they are almost completely normalized by renal transplantation.
Comparison of peritoneal dialysis (PD) with haemodialysis (HD) showed
that PD is associated with lower plasma protein pentosidine, possibly
due to selective transport of pentosidine-rich protein across the peri
toneal wall. Fractionation of plasma proteins from ESRD patients by si
ze showed that 90% of pentosidine is linked to HMW protein and 1-2% is
in free form. The mechanism of accelerated glycoxidation in ESRD is s
till not understood.